Lyell Immunopharma Inc. (LYEL)
0.65
-0.06 (-8.55%)
At close: Mar 03, 2025, 12:36 PM
Lyell Immunopharma Revenue
Lyell Immunopharma reported an annual revenue of $130K, reflecting a -99.85% growth. For the quarter ending September 30, 2024, Lyell Immunopharma generated $34K in revenue.
Revenue (ttm)
$130K
Revenue Growth
-99.85%
Price / Sales Ratio
3745.44
Revenue / Employee
$580.36
Employees
224
Market Cap
190.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 130K | -99.85% |
| 2022-12-31 | 84.68M | +695.15% |
| 2021-12-31 | 10.65M | +37.31% |
| 2020-12-31 | 7.76M | n/a |